Formula Swiss-logo
Formula Swiss, CEO Robin Roy Krigslund-Hansen
Formula Swiss has sold a 20% stake in Formula Swiss Medical to JuicyFields in a deal that values the medical cannabis company in Denmark at DKK +100 million.
BAAR, ZUG, SWITZERLAND, February 21, 2022 /EINPresswire.com/ — Formula Swiss AG of Switzerland has sold a 20% stake in Danish Formula Swiss Medical to Switzerland’s Juicy Fields AG in a deal that values the medical cannabis company in Denmark at more than DKK 100 million.
Formula Swiss, which was founded in Switzerland in 2013 by serial entrepreneur Robin Roy Krigslund-Hansen, was the majority shareholder in the Danish company since its launch in March last year, but retains a 40% stake.
Formula Swiss produces organic CBD products in Switzerland for customers in more than 60 countries as well as medical cannabis since 2019 for thousands of patients in Brazil. The company has companies in Denmark, the United Kingdom, Portugal, Romania and Thailand, among others.
CEO Robin Roy Krigslund-Hansen said:
“Formula Swiss Medical in Denmark has exceeded all expectations since its start-up last year and with this expansion of the ownership circle we get partners on board who know everything about the international market for THC products and medical cannabis. At the same time, they can sell more than we can produce. That’s good…
Original Author Link click here to read complete story..
Formula Swiss-logo
Formula Swiss, CEO Robin Roy Krigslund-Hansen
Formula Swiss has sold a 20% stake in Formula Swiss Medical to JuicyFields in a deal that values the medical cannabis company in Denmark at DKK +100 million.
BAAR, ZUG, SWITZERLAND, February 21, 2022 /EINPresswire.com/ — Formula Swiss AG of Switzerland has sold a 20% stake in Danish Formula Swiss Medical to Switzerland’s Juicy Fields AG in a deal that values the medical cannabis company in Denmark at more than DKK 100 million.
Formula Swiss, which was founded in Switzerland in 2013 by serial entrepreneur Robin Roy Krigslund-Hansen, was the majority shareholder in the Danish company since its launch in March last year, but retains a 40% stake.
Formula Swiss produces organic CBD products in Switzerland for customers in more than 60 countries as well as medical cannabis since 2019 for thousands of patients in Brazil. The company has companies in Denmark, the United Kingdom, Portugal, Romania and Thailand, among others.
CEO Robin Roy Krigslund-Hansen said:
“Formula Swiss Medical in Denmark has exceeded all expectations since its start-up last year and with this expansion of the ownership circle we get partners on board who know everything about the international market for THC products and medical cannabis. At the same time, they can sell more than we can produce. That’s good…
